Figure 5.
Effects of the 5-HT2AR agonist, TCB-2, and the 5-HT2AR antagonist, ketanserin, on the transcription level of KCC2, compared with the incision+DMSO group. The transcription of KC22 was measured using quantitative PCR after intrathecal delivery. (*P<0.05, **P<0.01). 5-HT2AR, 5-hydroxytryptamine 2A receptor; KCC2, potassium-chloride cotransporter 2; DMSO, dimethyl sulfoxide.